This report shows that interleukin (IL)17
BRIEF DEFINITIVE REPORT
Rheumatoid arthritis (RA) is a chronic systemic infl ammatory disease that primarily aff ects multiple joints. Autoimmune CD4 + T cells are required for the progression of RA, especially in an initial phase of the disease ( 1 ) . It is obscure, however, how such arthritogenic CD4 + T cells are produced in the immune system, become activated, and mediate RA. Recent studies with animal models have suggested that CD4 + T cells secreting IL-17 (IL-17A), called Th17 cells, may play a key role in the progression of RA as well as multiple sclerosis ( 2 -6 ) . Hindering the development of Th17 cells or blocking IL-17 activity indeed inhibits autoimmune pathology in these models ( 2 -6 ) . A particular cytokine milieu contributes to this preferential diff erentiation of naive self-reactive T cells to Th17 eff ector cells ( 2 -6 ) . In addition, the transcription factor ROR ␥ t specifi cally controls Th17 cell diff erentiation, indicating that Th17 cells form a T cell lineage distinct from Th1 or Th2 cells ( 7 ) . To further analyze the roles of Th17 cells in autoimmune disease, we have searched for cell-surface molecules that are specifi cally expressed in Th17 cells and are crucial for their functions, such as their migration to infl amed joints in RA.
The SKG strain of mice, a mutant on the BALB/c background, spontaneously develops T cell -mediated autoimmune arthritis, which clinically and immunologically resembles human RA ( 8 -10 ) . The strain harbors a recessive mutation of the gene encoding an Src homology 2 domain of -associated protein 70, a key signaling molecule in T cells. Impaired signal transduction through SKG -associated protein 70 results in thymic positive selection and failure 
BALB/c FR4 − CD4 + cells, and between IFN-␥ − / − CD4 + cells and IL-6 − / − CD4 + T cells transferred to RAG2 − / − mice, as described in the previous paragraph. The analysis revealed that 1,556 and 115 genes were up-regulated in 10-mo-old SKG FR4 − CD4 + and IFN-␥ − / − CD4 + T cells after homeostatic proliferation, respectively, with 29 genes shared by the two groups of genes ( Fig. 1 D ) . The 29 genes included those encoding cytokines, chemokines, and their receptors, such as IL-1R1, IL-17, IL-22, IL-21, CCR6, and CCL20 ( Fig. 1 E ; the rest of the genes are shown in Fig. S1 , available at http://www .jem.org/cgi/content/full/jem.20071397).
Expression of CCR6 by Th17 cells
With our interest in Th17 cell -specifi c cell-surface molecules, we analyzed CCR6 expressed by Th17 cells in young (2-mo-old) or aged (10-mo-old) SKG mice, or BALB/c Th17 cells induced via homeostatic proliferation ( Fig. 1 B ) . The majority of Th17 cells in SKG mice expressed CCR6 whether the mice were young or aged, whereas SKG Th1 cells did not ( Fig. 1 F ) . After cell transfer to RAG2 − / − mice, the majority of IL-17 + CD4 + T cells that had diff erentiated from IFN-␥ − / − or WT T cells were CCR6 + , whereas IFN-␥ + CD4 + T cells derived from WT CD4 + T cells were CCR6 − ( Fig. 1 G ) . Furthermore, IL-6 − / − CD4 + T cells not only failed to give rise to IL-17 + CCR6 + cells but also preferentially differentiated to IFN-␥ + CCR6 − cells ( Fig. 1 G ) .
It was also noted that CCR6 + cells, either IL-17 + or IL-17 − , increased in number among CD4 + T cells in aged SKG mice compared with aged BALB/c or young SKG mice ( Fig. 1 G and Fig. S2 B) . In addition, CCR6 − CD4 + T cells in BALB/c mice gave rise to IL-17 + CCR6 + CD4 + T cells via homeostatic proliferation when transferred to RAG2 − / − mice (Fig. S2 C) .
We also examined a possible correlation between CCR6 expression and transcription of the other genes depicted by the microarray analysis in Fig. 1 E or those genes reported to be functional in Th17 cells (e.g., IL-17, IL-17F, IL-21, IL-22, IL-1R1, IL-23R, and ROR ␥ t; Fig. 1 H ) ( 7, 13, 14 ) . When CCR6 + or CCR6 − CD4 + T cells purifi ed from aged SKG mice in the negative selection of highly self-reactive T cells that include potentially arthritogenic CD4 + T cells ( 8 ) . Our previous report showed that SKG CD4 + T cells spontaneously diff erentiated to arthritogenic Th17 cells, which were nonredundant in mediating SKG arthritis ( 6 ) . The study also showed that not only self-reactive CD4 + T cells in SKG mice but also naive T cells in normal mice were able to diff erentiate to Th17 cells when they were subjected to homeostatic proliferation in a T cell -defi cient environment ( 6 ) . In both systems, IL-6 defi ciency inhibited Th17 cell diff erentiation, whereas IFN-␥ defi ciency augmented it ( 6 ) . Use of these two in vivo Th17 cell induction systems allowed us to determine the genes commonly up-regulated in Th17 cells. We show in this report that Th17 cells predominantly express CC chemokine receptor (CCR) 6 and produce its ligand, CCL20. Infl amed synovial cells in both SKG arthritis and human RA also produce CCL20, facilitating the migration of arthritogenic Th17 cells to infl amed joints. Thus, CCR6 is an important functional marker for Th17 cells and contributes to their preferential migration to a particular infl ammation site.
RESULTS AND DISCUSSION
Gene microarray analysis of Th17 cells Th17 cells increase with age in SKG mice, constituting ‫ف‬ 3 -10% of LN CD4 + T cells at 10 mo of age compared with ‫ف‬ 0.2 -0.7% in age-matched BALB/c mice ( Fig. 1 A ) . Notably, they scarcely express the folate receptor 4 (FR4), which is highly expressed by CD25 + CD4 + natural regulatory T cells and central memory-like CD4 + T cells but not by eff ector or eff ector memory-like CD4 + T cells ( Fig. 1 A ) ( 11 -12 ) . Th17 cells can therefore be enriched by sorting FR4 − CD4 + T cells from SKG mice. A large number of Th17 cells also developed spontaneously when CD4 + T cells from IFN-␥ -defi cient (IFN-␥ − / − ) BALB/c mice were transferred to T cell -defi cient RAG2-defi cient (RAG2 − / − ) mice and subjected to homeostatic proliferation, whereas they failed to develop in a similar transfer of IL-6 -defi cient (IL-6 − / − ) CD4 + T cells to IL-6 − / − RAG2 − / − mice ( Fig. 1 B ) ( 6 ) . The numbers of Th17 cells assessed by cytofl uorometric analysis were well correlated with the amounts of the IL-17 protein secreted after in vitro stimulation with PMA/ionomycin ( Fig. 1 C ) .
To explore the functional molecules specifi cally expressed by Th17 cells, we conducted gene microarray analysis between 10-mo-old SKG FR4 − CD4 + cells and age-matched Previous studies with mice have shown that CCR6 is mainly expressed on memory T cells, some natural CD25 + CD4 + regulatory T cells, B cells, some DCs, and Langerhans cells, and suggested that CCR6 may be required for the traffi cking of these cells via CCL20 ( 15 -20 ) . The present results show that, in addition to these cell populations, Th17 cells also express CCR6 and that CCR6 expression can distinguish Th17 cells from Th1 cells. The condition that facilitates in vivo Th17 cell diff erentiation might also promote diff erentiation of naive CD4 + T cell to CCR6 + IL-17 − IFN-␥ − cells, which are FR4 high and, therefore, phenotypically similar to natural CD25 + CD4 + regulatory T cells and central memorylike T cells, as recently shown ( 12 ) , and in accord with the results by others (Fig. S4 , available at http://www.jem.org/ cgi/content/full/jem.20071397).
Induction of CCR6 in Th17 cells in vitro ROR ␥ t crucially controls Th17 cell differentiation from naive CD4 + T cells ( 7 ) . To test whether forced expression of ROR ␥ t directs the diff erentiation of CD4 + T cells to CCR6 + Th17 cells, ROR ␥ t was transduced in CCR6 − CD4 + T cells by a bicistronic retroviral vector expressing ROR ␥ t and GFP ( 7 ) . Notably, GFP-high (i.e., ROR ␥ t-high) cells expressed CCR6 as well as IL-17, whereas GFP-low cells did not ( Fig. 2,  A and B ) . Th17 cells can also be induced in vitro from naive CD4 + T cells by TCR stimulation in the presence of IL-6 and TGF-␤ , as reported by others ( 21 -23 ) . Interestingly, this in vitro induction of a large number of Th17 cells did not accompany CCR6 expression ( Fig. 2 C ) . Yet, further addition of IL-1, based on the high expression of IL-1R by IL-17 + cells ( Fig. 1 E and Fig. S3 ), elicited CCR6 expression in a doses used for in vitro Th17 cell induction ( 21 ) augmented CCL20 production by the adherent synoviocytes, whereas the addition of recombinant IFN-␥ or IL-4 inhibited production ( Fig. 3 A ) . Other Th17 cell -associated cytokines, such as IL-6, IL-22, and IL-23, had no signifi cant eff ect on the production at the doses used for controlling Th17 cell diff erentiation ( Fig. 3 A ) ( 21 -23 ) .
BRIEF DEFINITIVE REPORT
In addition to synoviocytes, purifi ed CCR6 + CD4 + SKG T cells actively transcribed CCL20 messenger RNA and secreted a large amount of the CCL20 protein compared with very low transcription or secretion by CCR6 − CD4 + SKG T cells ( Fig. 3, B and C ) . This concurred with the result of the microarray analysis, which showed a high expression of CCL20 by SKG FR4 − CD4 + T cells and BALB/c IFN-␥ − / − CD4 + T cells after homeostatic proliferation ( Fig. 1 E ) . In addition, Th17 cells that were induced in vitro from normal BALB/c CD4 + T cells by TCR stimulation in the presence of IL-6 and TGF-␤ produced a large amount of CCL20 ( Fig. 3 D ) .
Functionally, in vitro migration assays showed that CCR6 + CD4 + SKG T cells migrated in response to CCL20 in a dose-dependent manner and that the addition of an anti-CCR6 mAb, which blocks the binding of CCL20 to CCR6, eff ectively inhibited the migration at such low doses of CCL20 as those secreted by cultured synoviocytes in Fig. 3 A ( Fig. 3 E ) . Furthermore, CD4 + SKG T cells that had migrated in the presence of CCL20 were signifi cantly enriched for IL-17 + CD4 + T cells, but not for IFN-␥ + CD4 + T cells, small ( ‫ف‬ 15%) fraction of IL-17 + cells, whereas addition of IL-23, TNF-␣ , or IL-21 did not; the percentage further increased to ‫ف‬ 30% by neutralization of both IFN-␥ and IL-4 ( Fig. 2 C ) .
Collectively, these results indicate that, although IL-6 and TGF-␤ together can induce ROR ␥ t at an amount suffi cient for directing IL-17 production in vitro ( 7 ), a higher amount of ROR ␥ t or additional cytokines including IL-1 may be required for CCR6 expression. Our results also suggest that IFN-␥ and IL-4, both of which inhibit the diff erentiation of naive T cells to Th17 cells ( 3 ), may also suppress CCR6 expression in Th17 cells. CCL20 production by infl amed synoviocytes and Th17 cells CCL20 is so far known to be the sole ligand for CCR6 and able to direct the migration of CCR6 + cells ( 15 -19 ) . To assess the possible production of CCL20 in infl amed synovial tissue to attract arthritogenic Th17 cells, collagenase-digested synovial tissues from swollen ankle or wrist joints of SKG mice were in vitro cultured, as previously described ( 10 ), and the amounts of CCL20 in culture supernatants were measured by ELISA. The dispersed granulocytes and monocytes from the infl amed synovial tissue, or the splenocytes of arthritic mice, did not produce CCL20 without stimulation ( Fig. 3 A and not depicted) . Notably, adherent synovial cells, mainly fi broblast-like synoviocytes, spontaneously produced CCL20 ( Fig. 3 A ) . Adding recombinant IL-1 ␤ , IL-17, or TNF-␣ to the culture at the 
indicating that Th17 cells preferentially migrated in response to CCL20, whereas Th1 cells did not ( Fig. 3 F ) .
Collectively, these results indicate that both activated synoviocytes and CCR6 + Th17 cells themselves secrete CCL20 and further recruit other CCR6-expressing Th17 cells to the site of Th17 cell -mediated joint infl ammation.
The effect of CCR6 blockade on the initial phase of Th17 cell -mediated arthritis We previously reported that Th17 cells predominantly infi ltrated into the arthritic joints of SKG mice ( 6 ) . These infi ltrating Th17 cells indeed expressed CCR6, in contrast with infi ltrating Th1 cells, which were CCR6 − ( Fig. 4 A ) . To investigate the role of CCR6 on SKG autoimmune arthritis, we initially examined the eff ect of in vivo anti-CCR6 mAb treatment on lymphocytes. The anti-CCR6 mAb, which was used for in vitro CCR6 blockade ( Fig. 3 E ) , was not cell depleting in vivo: after one injection into SKG mice, it bound to CCR6 on the cell surface of B cells and a population of CD4 + T cells, and the binding persisted for at least 8 d ( Fig. 4 B and  Fig. S5 , available at http://www.jem.org/cgi/content/full/ jem.20071397). To assess the eff ect of this CCR6 blockade on the development of arthritis, we transferred SKG CD4 + T cells to syngeneic SCID mice and i.v. injected mAb once a week for 5 wk after cell transfer ( Fig. 4 C ) . The treatment signifi cantly suppressed the onset and severity of arthritis in an early phase: 3 wk after cell transfer, when control antibody -treated mice started to show joint swelling, much smaller number of T cells infi ltrated into the joints of anti-CCR6 -treated mice than control antibody -treated mice (Fig. S6) . Thus, the blockade of CCL20 binding to CCR6 could suppress the development of Th17 cell -mediated autoimmune arthritis, at least in the initial phase of disease progression, presumably by interfering with the traffi cking of Th17 cells ( 6 ) .
Production of IL-17 and CCL20 in arthritic joints of human RA We extended our analysis of IL-17 and CCR6/CCL20 in SKG arthritis to human RA. Synovial fl uid of RA patients contained signifi cantly higher amounts of IL-17 and CCL20 compared with osteoarthritis (OA) patients, in accord with other reports ( Fig. 5, A and B ) ( 24 -26 ) . A signifi cant correlation was observed between the amounts of IL-17 and IFN-␥ ( Fig. 5 C ) . Notably, however, the level of CCL20 in RA joints was well correlated with that of IL-17 but not of IFN-␥ ( Fig. 5, D and E ) . As in mice, intracellular staining of IL-17 and IFN-␥ or IL-4 of peripheral CD4 + T cells in normal healthy individuals showed that human Th17 cells were distinct from Th1 or Th2 cells and expressed CCR6, whereas CD4 + T cells producing IFN-␥ or IL-4 were CCR6 − (Fig. S7 , available at http://www.jem.org/cgi/content/full/jem.20071397), similar to the result recently reported on human Th17 cells in individuals with infectious diseases ( 27 ) . Collectively, these fi ndings suggest that Th17 cell traffi cking via CCR6/CCL20 may contribute to RA pathology.
We have thus shown that CCR6 and CCL20 are expressed by Th17 cells and are required for the migration of Th17 cells to initiate self-destructive immune reactions in the joints, leading to the development of autoimmune arthritis such as RA. Once synovial infl ammation occurs, synoviocytes may further recruit Th17 cells through CCL20 production, which is enhanced by proinfl ammatory cytokines produced by activated synoviocytes, such as IL-17, IL-1 ␤ , and TNF-␣ ( 9 ), and dampened by IFN-␥ or IL-4. Thus, Th1, Th2, and Th17 cell -produced cytokines, collectively with those produced by synoviocytes, form a cytokine milieu to cross-regulate not only the development of Th17 cells but also the traffi cking of CCR6 + Th17 cells via controlling the production of CCL20. It has been shown that joint infi ltration of CCR6 + T cells is associated with human RA, and high expression of CCL20 in the central nervous system is observed in an animal model of multiple sclerosis ( 25, 26, 28 -30 ) . It remains to be determined whether intervention in Th17 cell traffi cking via CCR6/CCL20 is useful to treat and prevent Th17 cell -mediated autoimmune diseases, including RA and multiple sclerosis. Such treatments include blocking CCR6 on Th17 cells at both the initial and chronic phases of disease progression and reducing the production of CCL20 by changing the cytokine milieu at infl ammation sites.
MATERIALS AND METHODS
Mice. BALB/c and SCID mice were purchased from Japan Clea. BALB/c IFN-␥ − / − mice were purchased from the Jackson Laboratory. IL-6 − / − mice were backcrossed to BALB/c mice more than eight times. RAG2 − / − BALB/c mice were a gift from Y. Shinkai (Kyoto University, Kyoto, Japan) and were crossed to IL-6 − / − mice to generate IL-6 − / − RAG2 − / − BALB/c mice. These mice were maintained in our animal facility under specifi c pathogen-free conditions and treated in accordance with the institutional guidelines for animal care at the Institute for Frontier Medical Sciences of Kyoto University. The animal experiments were approved by the animal ethics committee of the Institute for Frontier Medical Sciences.
Antibodies. The following reagents were purchased from BD Biosciences: anti-CD3 (145-2C11), anti-CD4 (RM4-5), anti-CD16/CD32 (2.4G2), anti-TCR ␣ ␤ (H57-597), anti-CCR6 (140706), anti -IL-4 (11B11), anti -IFN-␥ (XMG1.2), anti -IL-17 (TC11-18H10.1), PE-labeled goat anti -rat Ig, and isotype control IgG. Purifi ed anti -IL-6R (MR16-1) was a gift from N. Nishimoto (Osaka University, Osaka, Japan). Purifi ed anti-CCR6 (140706) was a gift from BD Biosciences. Anti-FR4 (Th6), which is of the rat IgG2a isotype, were purifi ed from the culture supernatant of the hybridoma and labeled in our laboratory, as previously described ( 12 ) . Intracellular cytokine staining. LN or spleen cells were stimulated with 20 ng/ml PMA and 1 M ionomycin in the presence of GolgiStop (BD Biosciences) for 5 h, stained for surface antigens, fi xed, and permeabilized using Cytofi x/Cytoperm (BD Biosciences), followed by anti -IL-17 and anti -IFN-␥ or IL-4 staining.
Measurement of cytokines and chemokines.
Mouse IL-17 and CCL20 were measured by ELISA using Quantikine M (R & D Systems), with a detection limit of 11 pg/ml and 3.9 pg/ml, respectively. Human IL-17, IFN-␥ (both from eBioscience), and CCL20 (R & D Systems) in synovial fl uid were measured by ELISA, with a detection limit of 4, 8, and 8 pg/ml, respectively.
Gene microarray analysis. Total RNA was extracted using the RNeasy Micro Kit (QIAGEN) and was subjected to gene microarray (GeneChip Mouse Genome 430 2.0 Array; Aff ymetrix). Analysis of gene expression was performed by GeneSpring software (Agilent Technologies). Microarray data are available from the National Center for Biotechnology Information Gene Expression Omnibus under accession no. GSE9316 .
Retroviral constructs and transduction.
Complementary DNA (cDNA) encoding full-length mouse Rorgt was amplifi ed by RT-PCR from the cDNA of SKG CD4 + T cells and cloned into the pMxs-IRES-GFP vector. Retroviral transduction was performed as previously described ( 7 ) . The pMxs-IRES-GFP vector was a gift from T. Kitamura (The University of Tokyo, Tokyo, Japan).
Preparation of synoviocytes. Synovial tissues from infl amed ankle joints were digested with 400 Mandl U/ml of Liberase Blendzyme II (Roche) in plain RPMI 1640 medium for 1 h at 37 ° C to prepare single-cell suspensions. Synovial cells were cultured in RPMI 1640 medium containing 20% FBS, and synoviocytes were prepared from the adherent cells.
Chemotaxis assay. Cell migration was evaluated using the 24-well, 5-m pore size Transwell system (Costar). 10 6 LN cells were placed on the top of the Transwell in RPMI 1640 containing 10 mM Hepes buff er. CCL20 was added to the bottom of the Transwell system in RPMI 1640 containing 10 mM Hepes buff er and 1% FBS. After 4 h of incubation at 37 ° C, the number of cells that had migrated into the lower well was analyzed by counting CCR6 + CD4 + cells for 3 min using a fl ow cytometer (FACSCalibur; BD Biosciences).
BRIEF DEFINITIVE REPORT
Analysis of synovial fl uid. Synovial fl uid was collected from RA patients, fulfilling the revised classification criteria of the American College of Rheumatology for RA, or OA patients during orthopedic operation under written informed consent. The experiments were approved by the ethics committee of the Kyoto University Graduate School and Faculty of Medicine.
Statistical analysis. The Student ' s t test was used for statistical analyses, unless indicated otherwise. P ≤ 0.05 was considered signifi cant.
Online supplemental material. Fig. S1 presents the 23 genes, among 29 genes commonly up-regulated in the two sets of analyses in Fig. 1 D , that are not encoding cytokines, chemokines, or their receptors. Fig. S2 shows the expression of CCR6 on BALB/c or SKG CD4 + T cells and the induction of CCR6 after homeostatic proliferation. Fig. S3 exhibits the expression of IL-1R1 on Th17 cells. Fig. S4 . shows that CCR6 + CD4 + T cells include not only IL-17 -producing cells but also TNF-␣ -producing cells and Foxp3 + cells. Fig. S5 shows that anti-CCR6 is not a cell-depleting antibody. Fig. S6 shows that the treatment of anti-CCR6 antibody inhibits the migration of CCR6 + CD4 + cells into the joints of the SCID mice that received cell transfer. Fig. S7 demonstrates the expression of CCR6 on human Th17 cells. Online supplemental material is available at http://www .jem.org/cgi/content/full/jem.20071397.
